• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

CVC buys 50% stake in DFE Pharma for NZD 633m
CVC buys 50% stake in DFE Pharma for NZD 633m

Sale price comprises a cash payment of NZD 537m and an interest-accruing vendor loan of NZD 96m

  • Buyouts
  • 25 September 2019
Palatine-backed Vernacare refinances
Palatine-backed Vernacare refinances

Palatine-backed medical equipment manufacturer Vernacare refinances its debt facilities

  • Exits
  • 19 September 2019
VCs in €40m series-D for Themis
VCs in €40m series-D for Themis

US-based Farallon Capital, with Oslo- and Stockholm-based Hadean Ventures, led the round for Themis

  • Early-stage
  • 18 September 2019
Investors back $240m series-C for CMR Surgical
Investors back $240m series-C for CMR Surgical

Existing investors in the round included LGT Capital Partners and Escala Capital Investments

  • Expansion
  • 18 September 2019
InnovaHealth backs Koelis
InnovaHealth backs Koelis

GP provides growth equity to French developer of medical imaging products Koelis

  • Expansion
  • 18 September 2019
Morningside leads €39m series-B for biotech company Inotrem
Morningside leads €39m series-B for biotech company Inotrem

Invus, Andera Partners, Sofinnova Partners and BiomedInvest also take part in the funding round

  • Early-stage
  • 12 September 2019
VC firms invest in $40m series-B for Anokion
VC firms invest in $40m series-B for Anokion

Anokion simultaneously announces the acquisition of US-based counterpart Kanyos Bio

  • Expansion
  • 12 September 2019
LSP leads €10.5m series-D for Xeltis
LSP leads €10.5m series-D for Xeltis

Life Sciences Partners first invested in the medical devices company in 2014

  • Early-stage
  • 09 September 2019
VC-backed ADC Therapeutics announces IPO
VC-backed ADC Therapeutics announces IPO

Plans to raise $150m through the offering and use the proceeds to advance its clinical trials

  • Exits
  • 09 September 2019
LSP, Gimv et al. back iStar Medical €40m series-C
LSP, Gimv et al. back iStar Medical €40m series-C

Series-C round will help Belgian medical device company to commercialise products

  • Expansion
  • 05 September 2019
Apposite's Riverdale bolts on Archway Dental Practice
Apposite's Riverdale bolts on Archway Dental Practice

Bolt-on follows the recent acquisitions of Hebburn and Pelaw dental practices, inked in August

  • Expansion
  • 05 September 2019
Syncona, RA lead £100m series-B for Achilles
Syncona, RA lead £100m series-B for Achilles

Syncona led a ТЃ13.2m funding round in 2016 for the cancer immunotherapy development company

  • Early-stage
  • 05 September 2019
Trilantic Europe's Oberberg makes two acquisitions
Trilantic Europe's Oberberg makes two acquisitions

Trilantic's portfolio company, mental health clinic group Oberberg, bolts on Panorama and Jägerwinkel

  • Portfolio management
  • 04 September 2019
Eurazeo, ADM in €60m round for M2I
Eurazeo, ADM in €60m round for M2I

Idinvest first invested in the pheromones and complex molecules producer in 2017

  • Expansion
  • 03 September 2019
IDG Capital et al. back $67m series-C for Hifibio
IDG Capital et al. back $67m series-C for Hifibio

Latest round follows $38m series-B led by Sequoia China and Lyfe Capital in Q2 2018

  • Early-stage
  • 29 August 2019
Grok among VCs in $100m Juvenescence series-B
Grok among VCs in $100m Juvenescence series-B

Biotechnology company's founders and cornerstone investors took part in the round

  • Expansion
  • 20 August 2019
Parkwalk, Oxford Sciences Innovation back MoA Technology
Parkwalk, Oxford Sciences Innovation back MoA Technology

VC firms provide the crop protection discovery company with a ТЃ6.3m series-A

  • Early-stage
  • 19 August 2019
Aquiline Capital-backed ClearCourse makes acquisition
Aquiline Capital-backed ClearCourse makes acquisition

e-clinic is the latest addition to the company's suite of businesses

  • Portfolio management
  • 19 August 2019
Equistone acquires Omnicare
Equistone acquires Omnicare

Lincoln International led a sales process for the wholesale anti-cancer pharmaceuticals distributor

  • Buyouts
  • 14 August 2019
PE-backed AskBio buys Synpromics
PE-backed AskBio buys Synpromics

Transaction comes four months after TPG and Vida took part in a $225m growth capital funding

  • Portfolio management
  • 14 August 2019
Mid Europa-backed Regina Maria buys Somesan Clinic
Mid Europa-backed Regina Maria buys Somesan Clinic

Addition of Somesan extends Regina Maria's reach to 19 counties and adds 20 outpatient clinics

  • Portfolio management
  • 13 August 2019
HTGF exits Cytena in €30.25m deal
HTGF exits Cytena in €30.25m deal

High-Tech Gründerfonds first invested in the company in 2015, and again in March 2019

  • Exits
  • 08 August 2019
Accelerated Ventures invests £3.5m in Biosignatures
Accelerated Ventures invests £3.5m in Biosignatures

Fresh capital will be used to analyse blood samples with the goal of developing 20 new tests

  • Expansion
  • 08 August 2019
Sovereign sells Outcomes First to Stirling Square's NFA
Sovereign sells Outcomes First to Stirling Square's NFA

Deal for the specialist care provider brings to an end a six-year holding period for the vendor

  • Exits
  • 07 August 2019
343536
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013